Connection

Jean-Charles Soria to Piperazines

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Piperazines.
Jean-Charles Soria
Connection Strength
1.254
Piperazines
  1. Osimertinib in EGFR Mutation-Positive Advanced NSCLC. N Engl J Med. 2018 03 29; 378(13):1262-1263.
    View in: PubMed
    Score: 0.567
  2. Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2018 01 11; 378(2):113-125.
    View in: PubMed
    Score: 0.553
  3. A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers. Clin Cancer Res. 2017 Sep 15; 23(18):5366-5373.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.